Colorectal carcinoma (CRC) · None
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Track | standard |
|---|---|
| Linked regimen | None |
| ID | IND-LYNCH-CARRIER-SURVEILLANCE |
|---|---|
| Type | Indication |
| Status | reviewed 2026-05-18 | pending_clinical_signoff |
| Diseases | DIS-CRC |
| Sources | SRC-ASCO-ACMG-LYNCH-2014 SRC-ESMO-CRC-2024 SRC-NCCN-GENETIC-FAMILIAL-CRC-2025 |
Notes
STUB — v0.2-B confirmed-carrier surveillance pathway (Lynch). Two-Clinical-Co-Lead signoff queued. Sibling — IND-LYNCH-CARRIER-INTENSIFIED (aggressive plan_track).
Used By
Actionability
BMA-AXIN2-GERMLINE-CRC-OLIGODONTIA- AXIN2 germline pathogenic variants cause a Lynch-like attenuated polyposis + oligodontia...BMA-MSH3-GERMLINE-POLYPOSIS-BIALLELIC- MSH3 germline biallelic pathogenic variants cause MSH3-associated polyposis (Adam et al....BMA-NTHL1-GERMLINE-NAP-BIALLELIC- NTHL1 germline biallelic (homozygous or compound heterozygous) pathogenic variants cause...BMA-POLD1-GERMLINE-POLYMERASE-PROOFREADING- POLD1 germline pathogenic variants in the exonuclease (proofreading) domain cause PPAP —...BMA-POLE-GERMLINE-POLYMERASE-PROOFREADING- POLE germline pathogenic variants in the exonuclease (proofreading) domain cause polymera...
Indication
IND-CASCADE-LYNCH-FDR-POSITIVE-TESTING- IND-CASCADE-LYNCH-FDR-POSITIVE-TESTINGIND-LYNCH-CARRIER-INTENSIFIED- IND-LYNCH-CARRIER-INTENSIFIED
Red flag
RF-LYNCH-CONFIRMED-CARRIER- Confirmed germline pathogenic / likely-pathogenic variant in a Lynch syndrome (MMR / EPCA...RF-LYNCH-FAMILY-HISTORY-SUSPICION- Family pedigree meeting criteria suggestive of hereditary nonpolyposis colorectal cancer...